Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy

Junbo Ge^{1

2}

Affiliations

¹ Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. jbge@zs-hospital.sh.cn.
² Shanghai Institute of Cardiovascular Diseases, Shanghai, China. jbge@zs-hospital.sh.cn.

Junbo Ge. Cardiol J. 2020.

. 2020;27(1):97-98.

doi: 10.5603/CJ.2020.0023.

Junbo Ge^{1

2}

¹ Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. jbge@zs-hospital.sh.cn.
² Shanghai Institute of Cardiovascular Diseases, Shanghai, China. jbge@zs-hospital.sh.cn.

No abstract available

Conflict of interest statement

Conflict of interest: None declared

Left ventricular ejection fraction… What else?
Jiménez-Blanco M, Cordero D, Zamorano JL. Jiménez-Blanco M, et al. Cardiol J. 2020;27(1):6-7. doi: 10.5603/CJ.2020.0014. Cardiol J. 2020. PMID: 32103477 Free PMC article. No abstract available.

1. Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019;381(17):1609–1620. doi: 10.1056/NEJMoa1908655. - DOI - PubMed
1. Shah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2012;9(10):555–556. doi: 10.1038/nrcardio.2012.123. - DOI - PubMed
1. Shah SJ, Katz DH, Deo RC. Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Fail Clin. 2014;10(3):407–418. doi: 10.1016/j.hfc.2014.04.008. - DOI - PMC - PubMed
1. Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598–1617. doi: 10.1161/CIRCRESAHA.119.313572. - DOI - PMC - PubMed
1. Saiki H, Petersen IA, Scott CG, et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation. 2017;135(15):1388–1396. doi: 10.1161/CIRCULATIONAHA.116.025434. - DOI - PMC - PubMed